Related Experiment Video

Updated: Dec 21, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.7K

Pazopanib as a potential chemotherapy for cutaneous angiosarcoma: A case series of 10 patients from a single

Susumu Fujiwara1, Eiji Nakano1, Korefumi Nakamura1

  • 1Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan.

The Journal of Dermatology
|May 14, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.8K
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

13.1K

Related Experiment Videos

Last Updated: Dec 21, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.7K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.8K
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

13.1K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K

Articles linked to this work by shared authors, journal, and citation graph.

No demonstrated superiority of tropomyosin (Pen a 1) sIgE over crude shrimp sIgE in children.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026

Melanoma Recurrence Prediction Using a Tissue-Free Epigenomic Molecular Residual Disease Assay: A Multicenter Prospective Observational Study (COSMOS-MEL01).

Cancer research communications·2026

Genomic Landscape of Primary and Secondary Cutaneous Angiosarcoma: A Single-Center Retrospective Cohort Analysis in Japan.

The Journal of dermatology·2026

Three Cases of Merkel Cell Carcinoma Treated With Lutetium-177 Oxodotreotide.

The Journal of dermatology·2026

Efficacy of Adjuvant Interferon-β Versus Observation for Resected Nail Apparatus Melanoma: A Multicenter Retrospective Study.

The Journal of dermatology·2026

An Exploratory Study of the Effects of a High School-University Collaborative Program on Learning Motivation and Professional Understanding among Students Aspiring to Enter Medical School.

Juntendo medical journal·2026

Upregulated ST2L-Dependent IL-33 Signaling in Dermal Fibroblasts Contributes to IL-6 Induction and Skin Fibrosis in Systemic Sclerosis.

The Journal of dermatology·2026

Long-Term Follow-Up of Epidermolysis Bullosa Acquisita with Fluctuations in Serum Cytokine Levels: A Case Report.

The Journal of dermatology·2026

Diagnostic Utility of Full-Length BP180 and Native BP180-α6β4 Integrin Complex ELISAs in Serologically Inconclusive Mucous Membrane Pemphigoid.

The Journal of dermatology·2026

Dermatological Needs After the 2026 Kumamoto Earthquake.

The Journal of dermatology·2026

Clinical Study of Bullous Pemphigoid With Oral Mucosal Symptoms After Oral Administration of Dipeptidyl Peptidase-4 Inhibitors.

The Journal of dermatology·2026

Non-Pharmacological Psychosomatic Approaches to Patients With Atopic Dermatitis: A Delphi Consensus of Expert Opinions in Japan.

The Journal of dermatology·2026

NMA plus antitumor therapy versus antitumor therapy alone in patients with BCLC stage B or C hepatocellular carcinoma and pre-cachexia or cachexia: protocol for a prospective, multicenter, randomized, open-label phase II trial.

Frontiers in gastroenterology (Lausanne, Switzerland)·2026

Cannabinoids in oncology: pharmacology, clinical applications, and translational perspectives.

Frontiers in pharmacology·2026

Phytochemicals in colorectal cancer therapy: emerging mechanisms, translational opportunities, and global research evolution.

Journal of materials chemistry. B·2026

Untargeted salivary metabolomics for early prediction of chemotherapy-induced oral toxicities in patients with oral squamous cell carcinoma.

Odontology·2026

Lessons from oncology: Can cancer lead the way in resistance management?

Evolution, medicine, and public health·2026

Cannabis Co-Use and Endocannabinoid System Modulation in Tobacco Use Disorder.

Neuroscience and biobehavioral reviews·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us